Thor Medical ASA (TRMED.OL)

NOK 2.66

(1.92%)

Net Debt Summary of Thor Medical ASA

  • Thor Medical ASA's latest annual net debt in 2023 was -41.28 Million NOK , up 57.17% from previous year.
  • Thor Medical ASA's latest quarterly net debt in 2024 Q2 was -29.6 Thousand NOK , up 3.04% from previous quarter.
  • Thor Medical ASA reported annual net debt of -96.39 Million NOK in 2022, up 64.46% from previous year.
  • Thor Medical ASA reported annual net debt of -271.2 Million NOK in 2021, up 5.94% from previous year.
  • Thor Medical ASA reported quarterly net debt of -29.6 Thousand NOK for 2024 Q1, up 99.93% from previous quarter.
  • Thor Medical ASA reported quarterly net debt of -41.28 Million NOK for 2023 FY, up 57.17% from previous quarter.

Annual Net Debt Chart of Thor Medical ASA (2023 - 2019)

Historical Annual Net Debt of Thor Medical ASA (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -41.28 Million NOK 57.17%
2022 -96.39 Million NOK 64.46%
2021 -271.2 Million NOK 5.94%
2020 -288.31 Million NOK 0.0%
2019 - NOK 0.0%

Peer Net Debt Comparison of Thor Medical ASA

Name Net Debt Net Debt Difference
Arctic Bioscience AS -77.55 Million NOK 46.767%
Aqua Bio Technology ASA -5.82 Million NOK -608.279%
ArcticZymes Technologies ASA -237.27 Million NOK 82.601%
BerGenBio ASA -155.55 Million NOK 73.46%
Hofseth BioCare ASA 112.89 Million NOK 136.567%
PCI Biotech Holding ASA -40.86 Million NOK -1.028%
Ultimovacs ASA -262.84 Million NOK 84.293%